Inflammation, Skin Patents (Class 514/886)

Cross-Reference Art Collections

Topical treatment (Class 514/887)
  • Patent number: 6423343
    Abstract: This invention relates to a method for treating inflammatory symptoms such as burning, redness, itching, swelling and pain which accompany skin disorders other than wounds of the skin. The method comprising topical application of a topical medicinal composition comprising a non-interlinked, particulate bioactive glass mixed with a topical medicinal carrier to the site of the skin disorder.
    Type: Grant
    Filed: January 23, 1998
    Date of Patent: July 23, 2002
    Assignee: USBiomaterials Corporation
    Inventors: Sean Lee, James L. Meyers
  • Patent number: 6416790
    Abstract: The concentrate is a liquid mixture of about 1000 parts by volume of ultra pure water having an electrical resistance of 16-26 megohms, total dissolved solids of less than 0.04 parts per million and a specific conductance of less than 0.10 microhmo to about 1.2 to 3 parts by volume of Willard Water as prepared in accordance with U.S. Pat. No. 3,893,943. The liquid concentrate is applied directly to a skin surface area having a burn or other dermal lesion to protect the area from bacterial contamination.
    Type: Grant
    Filed: March 13, 2000
    Date of Patent: July 9, 2002
    Assignee: Aqua Med, Inc.
    Inventor: John D. Young
  • Patent number: 6413547
    Abstract: This invention relates to novel, liquid crystal forms of the cyclic peptide cyclosporin and to novel powder formulations of cyclosporin prepared using this novel liquid crystal form of the drug. Methods for preparing and using these formulations are also provided. In particular, the present invention relates to dispersible spray dried particles of cyclosporin suitable for pulmonary delivery.
    Type: Grant
    Filed: February 11, 1999
    Date of Patent: July 2, 2002
    Assignee: Inhale Therapeutic Systems, Inc.
    Inventors: David B. Bennett, Kirsten M. Cabot, Linda C. Foster, David Lechuga-Ballesteros, John S. Patton, Trixie K. Tan
  • Patent number: 6413525
    Abstract: The present invention relates to a method of exfoliating and moisturizing the skin comprising the steps of topically applying a cosmetic or pharmaceutical composition. The composition comprises an amino sugar, N-acetyl-D-glucosamine and related compounds.
    Type: Grant
    Filed: May 6, 1999
    Date of Patent: July 2, 2002
    Assignee: Color Access, Inc.
    Inventors: Thomas Mammone, David C. Gan
  • Patent number: 6399108
    Abstract: The present invention is directed to methods and compositions for treating skin disorders. The present invention is easily administered and can be used for both humans and animals. The compositions of the present invention comprise borate compounds and provide relief from skin disorder symptoms and lesions. Additionally, the present invention can be used to provide long term maintenance of symptom-free skin.
    Type: Grant
    Filed: June 30, 2000
    Date of Patent: June 4, 2002
    Assignee: P.H.C., Inc.
    Inventor: Don H. Girvan
  • Patent number: 6399112
    Abstract: This application relates to a material which is suitable for the treatment of atopic disease, non-atopic eczema or psoriasis. The material can be extracted from a freeze-dried decoction of a mixture comprising the following Chinese herbs: Radix Ledebouriella, Fructus Tribuli, Herba Potentilla chinensis, Caulis Clematis armandii, Radix Rehmannia, Radix Glycyrrhiza, Radix Paeonia rubra, Cortex Dictamni radicis, Herba Lopatheri, Spica Schizonepetae. The material comprises one or more of those components present in the freeze-dried decoction which run with Rf values in the ranges 0.00 to 0.100, 0.167 to 0.300, 0.400 to 0.533, 0.700 to 0.833 or 0.900 to 0.967 if the freeze-dried decoction is diluted in aqueous solution and subjected to chromatography on a Whatman 2 cms×55 cms×3 mm cellulose strip for 10 hours using a solvent mixture of butanol, ethanol and water in the proportions 4:1:1.
    Type: Grant
    Filed: December 24, 1996
    Date of Patent: June 4, 2002
    Assignee: Phytotech Limited
    Inventors: Brian Anthony Whittle, Jonathan Brostoff, Yvette Latchman
  • Patent number: 6395309
    Abstract: Use of an extract of alchemilla vulgaris, or a fraction or a lyophilizate thereof, or one or more active principles contained in said extract, for inhibiting angiogenesis.
    Type: Grant
    Filed: December 22, 1999
    Date of Patent: May 28, 2002
    Assignee: Weber & Weber GmbH & Co. KG
    Inventors: Gerhard Franz, Dietrich H. Paper
  • Patent number: 6392100
    Abstract: 2-Cyclopenten-1-one and its derivatives comprising the cyclopentenone nucleus as inhibitors of the NF-kB factor, with anti-inflammatory, anti-proliferative, immunosuppressive, cytoprotective and antiviral activity, the substituents being selected among the ones which do not affect the NF-kB inhibitory activity. Further the cyclopentenone derivative is a cyclopentenone compound which does not have two adjacent aliphatic side chains or a prostaglandin.
    Type: Grant
    Filed: June 10, 1999
    Date of Patent: May 21, 2002
    Assignee: Consiglio Nazionale Delle Richerche
    Inventors: Maria Gabriella Santoro, Antonio Rossi, Giuliano Elia
  • Patent number: 6387383
    Abstract: A composition is provided that has a viscosity of less than about 15,000 cP and a pH of about 3.0 to 9.0 for treating a skin disorder in a human subject. The composition consists essentially of (a) a therapeutically-effective amount of at least one compound useful for treating such disorder, (b) a pharmaceutically-acceptable, lightly cross-linked polyacrylic acid polymer compatible with the compound, (c) optionally a water miscible solvent, (d) optionally a preservative, (e) optionally an oil phase component and suitable surfactant, and (f) water. The composition is useful for treating an inflammatory skin disorder, acne, or rosacea. The low viscosity composition has an advantage of being administered more accurately when combined with a container that administers the composition as drops.
    Type: Grant
    Filed: August 3, 2000
    Date of Patent: May 14, 2002
    Assignee: Dow Pharmaceutical Sciences
    Inventors: Gordon J. Dow, Robert W. Lathrop, Debra A. Dow
  • Patent number: 6387407
    Abstract: Topical gelled compositions comprising an optional drug dispersed within a polymer matrix, methods of producing the same and treatments with the complex.
    Type: Grant
    Filed: March 30, 1999
    Date of Patent: May 14, 2002
    Assignee: L.A.M. Pharmaceutical Corporation
    Inventors: Alan Drizen, Peter Rothbart, Gary M. Nath
  • Patent number: 6383495
    Abstract: The invention provides a novel herbal formulation useful for the treatment of skin disorders and comprising two or more plant extracts selected from Tagetes erecta, Moringa oleifera, Ocimum sanctum, Tridax procumbens, Aloe vera, and Gum olibanum together with conventional additives.
    Type: Grant
    Filed: September 11, 2000
    Date of Patent: May 7, 2002
    Assignee: Council of Scientific & Industrial Research
    Inventors: Sistla Ramakrishna, Bhamidipalli Subrahmanya Sitaramam, Prakash Vaman Rao Diwan, Kondapuram Vijaya Raghavan
  • Patent number: 6379713
    Abstract: A method of treatment for a mammal in need of analgesia from an itching skin comprising applying by directional friction against the skin proximate to the itch a composition consisting essentially of dry elemental iodine in the form of an amorphous condensate. The method is found effective in producing analgesia to the affected skin within 1 to 5 minutes after application.
    Type: Grant
    Filed: March 23, 2001
    Date of Patent: April 30, 2002
    Inventor: André Reiss
  • Patent number: 6379673
    Abstract: The invention provides a herbal formulation useful as a therapeutic and cosmetic applications for the treatment of general skin disorders, said composition comprising at least two or more plant extracts in the form of oil or powder or mixtures thereof, the said plants extracts being selected from the group consisting of Gymnena sylvestrae water extract 3 to 6 wt. %; Tridax procumbens water extract 3 to 6 wt. %; its methanolic extract 4 to 6 wt. %, Allium sativum oilhexane extract 1 to 3 wt. %; dried juice of Aloe vera 2 to 6 wt. %; Gum olibanum powder in the natural form 4 to 7 wt. %; Gum olibanum resinoid or its organic extract 3 to 8 wt. %; and resinoid free Gum olibanum meal 5 to 10 wt. %., optionally, including any drug having anti-inflammatory and wound healing property or mixture thereof, the said drug being selected from the group consisting of Disclofenac sodium 1-3 wt. %, Salicyclic acid 1 to 4 wt. %, Piroxicam 1 to 2 wt. %, Turmeric powder 0.1 to 1 wt.
    Type: Grant
    Filed: October 18, 2000
    Date of Patent: April 30, 2002
    Assignee: Council of Scientific and Industrial Research
    Inventors: Prakash Vaman Rao Diwan, Bhamidipalli Subrahmanya Sitaramam, Sistla Ramakrishna, Kondapuram Vijaya Raghavan
  • Patent number: 6372785
    Abstract: The invention provides novel anthracene compounds useful in the treatment of allergic, inflammatory, and tumor conditions and therapeutic compositions containing such compounds or their pharmaceutically acceptable salts. The compounds of the invention are novel 1,8-dichloro-anthracene derivatives or analogs thereof. According to the practice of the invention, there are provided 9-substituted 1,8-dichloro-anthracene compounds of the Formula III: wherein R represents a straight or branched chain alkyl group having 1-6 carbons and may be substituted with one or more of the groups R1, wherein R1 represents the groups selected from COOH or an ester alky thereof having 1 to 4 carbons, —OH, halogen, NO2, CH3O, CH3CH2O, phenyl and CH3CH2CH2O.
    Type: Grant
    Filed: May 4, 2000
    Date of Patent: April 16, 2002
    Assignee: Keith Chan, President GloboAsia, LLC
    Inventor: Hsu-Shan Huang
  • Patent number: 6361806
    Abstract: Emollient compositions for topical administration consisting of hydrophilic:hydrophobic emulsions containing a polyacrylate carrier, a vehicle, a mixture of C16:0, C18:0, C18:1 fatty acids and derivatives as penetrants, a balanced mixture of unsaturated C18:2, C18:2 and C18:3 fatty acids, a natural anti-inflammatory compound, a natural analgesic compound, a natural estrogenic compound and a fragrance; Methods of their use for ameliorating symptoms of disease including mammary fibrocystic disease, cyclic mastitis, inflammation and general and specific pre- and post-menopausal pain and swelling.
    Type: Grant
    Filed: February 23, 2000
    Date of Patent: March 26, 2002
    Inventor: Michael P. Allen
  • Patent number: 6350476
    Abstract: The present invention provides compositions comprising the ingredients of plants of species of the genera Stephania, Coix, Pinellia, Prunus, Phellodendron, Sophora, Tetrapanax, Stemona, Glycyrrhiza, Tripterygium, Forsythia and Siegesbeckia, wherein such compositions have analgesic, antipyretic, and antiinflammatory properties. The present invention also provides methods of using such compositions for treating various conditions and diseases, including joint swelling, joint pain, osteoarthritis and rheumatoid arthritis.
    Type: Grant
    Filed: May 22, 2000
    Date of Patent: February 26, 2002
    Assignee: Shanxi Zhengzhon Pharmaceutical Co., Ltd.
    Inventor: Liping Hou
  • Patent number: 6344214
    Abstract: Astaxanthin is a potent antioxidant, over 500 times more powerful than Vitamin E and 10 times stronger than other carotenoids such as zeaxanthin, lutein, canthaxanthin and beta-carotene. Astaxanthin has also been shown to enhance and modulate the immune system and diminish the damaging effects of UVA sunlight. Disclosed is a method for retarding and ameliorating fever blisters (cold sores) and canker sores. The method comprises administering a source of astaxanthin in a therapeutically effective amount to prevent, retard and ameliorate fever blisters and canker sores. The astaxanthin may be administered orally, topically, or in a combination of oral and topical dosage.
    Type: Grant
    Filed: December 13, 1999
    Date of Patent: February 5, 2002
    Assignee: Cyanotech Corporation
    Inventor: R. Todd Lorenz
  • Patent number: 6333341
    Abstract: Selected novel substituted pyridine compounds are effective for prophylaxis and treatment of diseases, such as TNF-&agr;, IL-1&bgr;, IL-6 and/or IL-8 mediated diseases, and other maladies, such as pain and diabetes. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving inflammation, pain, diabetes, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
    Type: Grant
    Filed: August 21, 2000
    Date of Patent: December 25, 2001
    Assignee: Amgen Inc.
    Inventors: Nathan B. Mantlo, Stephen T. Schlachter, John A. Josey
  • Patent number: 6329362
    Abstract: Compounds of formula (1) are described: wherein L1 is a covalent bond or a linker atom or group; R is a carboxylic acid (—CO2H) or a derivative threof; R6 and R7 which may be the same or different is each an atom or group —L2(Alk2)tL3R12 in which L2, L3, Alk2 and t are as previously defined and R12 is a hydrogen or halogen atom or an —OR9, —NR9R10, —NO2, —CN, —CO2R9, —CONR9R10, —COR9, —N(R9)COR10, —N(R9)CSR10, —SO2N(R9)(R10), —N(R9)SO2R9, —N(R9)CON(R10)(R11), —N(R9)CSN(R10)(R11), —N(R9)SO2N(R10)(R11), or an optionally substituted aliphatic, heteroaliphatic, cycloaliphatic, heterocycloaliphatic, aromatic or heteroaromatic group provided that R6 and R7 are not both hydrogen atoms and when R7 is a hydrogen atom then R4 and R5 is each a hydrogen or halogen atom or an alkyl, alkoxy or nitro group; and the salts, solvates, hydrates and N-oxides thereof, for use in modulating cell adhesion.
    Type: Grant
    Filed: March 16, 1999
    Date of Patent: December 11, 2001
    Assignee: Celltech Therapeutics Limited
    Inventors: Sarah Catherine Archibald, John Clifford Head, Graham John Warrellow, John Robert Porter
  • Patent number: 6328978
    Abstract: Methods for the treatment of skin disorders, including psoriasis, atopic dermatitis, allergic contact dermatitis, alopecia areata and skin cancers are provided, such methods comprising administering a composition having antigenic and/or adjuvant properties. Compositions which may be usefully employed in the inventive methods include inactivated M. vaccae cells, delipidated and deglycolipidated M. vaccae cells, M. vaccae culture filtrate and compounds present in or derived therefrom, together with combinations of such compositions.
    Type: Grant
    Filed: June 2, 1999
    Date of Patent: December 11, 2001
    Assignee: Genesis Research & Development Corp. Ltd.
    Inventors: James D. Watson, Paul L. J. Tan, Ross Prestidge
  • Patent number: 6329340
    Abstract: The present invention relates to a human polypeptide defensin Def-X, homologous to HNP-4, its genomic DNA and cDNA, vectors, cells transformed with said vectors, the use of said polypeptides as antibiotic, cytotoxic, repair and endocrine regulatory agent and as pesticide as well as cosmetic or pharmaceutical compositions for the treatment of microbial infections, in particular bacterial, fungal and viral infections, or parasitic infections, cancers, of inflammation and of immune deficiency. Finally, the invention comprises diagnostic methods and kits for the determination of a microbial or parasitic infection and of an inflammation, or for screening for predisposition to immune deficiencies or cancer diseases.
    Type: Grant
    Filed: February 25, 2000
    Date of Patent: December 11, 2001
    Assignee: Genset S.A.
    Inventors: Lydie Bougueleret, Ilya Chumakov
  • Patent number: 6329343
    Abstract: A bioadhesive wound-healing composition includes pullulan, pyruvate, an antioxidant, and a mixture of saturated and unsaturated fatty acids. The composition can be provided in the form of a film that does not self-adhere. The composition can include additional medicinal agents, such as polymyxin B sulfate, bacitracin zinc, and neomycin sulfate. Methods for producing the composition and methods for treating wounds with the composition are also disclosed.
    Type: Grant
    Filed: February 25, 2000
    Date of Patent: December 11, 2001
    Assignee: Warner-Lambert Company
    Inventors: Sau-Spence Leung, Alain Martin, Robert S. Leone
  • Patent number: 6309675
    Abstract: A therapeutic composition having plantain and aloe vera constituents is useful in the treatment of the symptoms of arthritis and other afflictions. The therapeutic composition may have only plantain and aloe vera constituents, wherein the plantain constituent is in a range of approximately 57% to 61% by weight of the therapeutic composition and the aloe vera constituent is in a range of approximately 39% to 43% by weight of the therapeutic composition. The therapeutic composition may have other constituents, such as herbal tinctures, added for various purposes, in which case, the plantain constituent is in a range of approximately 51% to 58% by weight of the therapeutic composition, the aloe vera constituent is in a range of approximately 37% to 39% by weight of the therapeutic composition, and the other constituent is in the range of approximately 5% to 10% by weight of the therapeutic composition.
    Type: Grant
    Filed: July 21, 1999
    Date of Patent: October 30, 2001
    Inventor: Nancy Laning Sobczak
  • Patent number: 6303651
    Abstract: A composition and method of treating cutaneous infection and resulting inflammation in animals known as hot spots and mange, respectively, as well as related veterinarian dermatological conditions. The composition includes L-glutathione and a source of selenium which act synergistically and which are included in a suitable topical carrier for topical application.
    Type: Grant
    Filed: September 23, 1999
    Date of Patent: October 16, 2001
    Assignee: Thione International, Inc.
    Inventor: Theodore Hersh
  • Patent number: 6287580
    Abstract: A self-warming cosmetic composition is provided which delivers skin conditioning agents and is based upon a redox system of iron powder and a catalyst such as charcoal to provide the warmth. The system is activated with moisture and air.
    Type: Grant
    Filed: April 26, 2000
    Date of Patent: September 11, 2001
    Assignee: Unilever Home & Personal Care USA, a division of Conopco, Inc.
    Inventors: Robert Edward Gott, Craig Stephen Slavtcheff, Alexander Paul Znaiden, Brian Andrew Crotty
  • Patent number: 6277846
    Abstract: The invention relates to a method for treating pruritus by administering a therapeutically effective amount of a PAF antagonist to a mammal afflicted with pruritus. The PAF antagonists may, for example, be selected from synthetic PAF analogues, natural products isolated from plants having PAF antagonist activity, and triazolobenzodiazepines. The PAF antagonists are preferably applied topically to the afflicted site but systemic such as oral, parenteral, nasal and intrarectal administration, is also possible.
    Type: Grant
    Filed: August 24, 1998
    Date of Patent: August 21, 2001
    Assignee: Allergan Sales, Inc.
    Inventors: David F. Woodward, Linda Sue Williams
  • Patent number: 6270811
    Abstract: The invention concerns a cosmetic or pharmaceutical composition. This composition is characterised in that it contains a microbial culture compatible in cosmetics or in pharmacy or in therapy, in particular a culture of micro-organisms selected among the acetic or lactic bacteria, freeze-dried yeast, suspensions of micro-organisms, fermented organic substances, for example fermented pollen, or an inactivated culture of bacteria of the genus bifidobacterium or of bacteria related to this genus mixed with an essential oil and an acid preferably an organic acid, such as citric acid. This composition has an activity for regenerating the skin, in particular anti-wrinkle properties, for erasing old scars, for repairing burnt tissues, for promoting skin healing, for eliminating pigmentary spots and also for promoting growth or fresh growth of superficial body growth including nails, hair or hairs.
    Type: Grant
    Filed: May 25, 1999
    Date of Patent: August 7, 2001
    Assignee: 1 Fois 1 Jour Concept
    Inventor: Alexandra Fregonese
  • Patent number: 6267962
    Abstract: Novel compositions containing at least one biologically active component derived from peat or similar composition, methods for their preparation and therapeutic uses for a variety of diseases, injuries, and conditions, including wound healing, pain, itch, inflammation, abnormal cell proliferation, or infections caused by fungal, bacterial, rickettsial or viral agents, psoriasis, allergic and other dermatitis, pruritis, eczema, actinic keratosis and similar conditions. In addition, the compositions can be used as diuretics, antiarrhythmics, and cardiac-stimulating agents, as well as for the treatment of mammalian diseases and disorders, including multiple drug resistance, cancers, asthma, rheumatoid arthritis, pain, wound healing, fungal disorders, and other inflammatory disorders. The compositions are derivable from peat or peat-related substances and may alternatively be synthetically produced.
    Type: Grant
    Filed: June 30, 1997
    Date of Patent: July 31, 2001
    Assignee: C-P Technology Limited Partnership
    Inventors: Ralph M. Hart, Herman L. Jones, Veronica Lee Egelkrout Jones, Sohail Malik, Margaret A. Kenny, Bernard Loev, James P. Harnisch
  • Patent number: 6264963
    Abstract: An improved skin care composition having enhanced skin hydration, moisturizing, conditioning, and cosmetically acceptable tactile properties. The composition includes a skin hydration system comprising glycerin and plant-derived oil; petrolatum or mineral oil; a di-lower alkyl di-higher alkyl ammonium emulsifier; a fatty alcohol; a fatty ester emollient; and water. Additional components include a humectant system and a lubricant.
    Type: Grant
    Filed: July 1, 1999
    Date of Patent: July 24, 2001
    Inventors: David H. Leifheit, David M. Buri
  • Patent number: 6258830
    Abstract: The present invention provides a stable gel formulation for topical treatment of skin conditions in humans. The stable gel formulation includes an active agent, having activity for treatment of acne and psoriasis, which is insoluble in water and a plurality of nonaqueous vehicles for both solubilizing said active agent and forming a gel therewith enabling topical application of the gel to a skin condition. The plurality of vehicles are each present in amounts, and in combination, to control release of the active agent from-the gel to the skin condition.
    Type: Grant
    Filed: March 1, 1999
    Date of Patent: July 10, 2001
    Assignee: Allergan Sales, Inc.
    Inventor: Prakash M. Charu
  • Patent number: 6251371
    Abstract: The present invention relates to use of dichlorobenzyl alcohol for preparing a preparation for topical treatment of inflammation and the preparation for this purpose. It is known to use dichlorobenzyl alcohol (2,4-DCBA) as an agent against bacteria and fungi, i.e. as a disinfectant. By the present invention it has, however, surprisingly turned out that dichlorobenzyl alcohol, preferably 2,4-dichlorobenzyl alcohol, is also useful for treatment of inflammation. The invention also relates to a preparation containing dichlorobenzyl alcohol, preferably 2,4-dichlorobenzyl alcohol, for topical treatment of inflammation, which can be applied onto skin or mucosa in the form of an ointment, a cream, a gel or a solution. Thus, the preparation has turned out to be effective against a variety of inflammatory conditions including skin diseases, such as pruritus and psoriasis, insect bites and stings.
    Type: Grant
    Filed: August 30, 1999
    Date of Patent: June 26, 2001
    Assignee: Bifodan A/S
    Inventors: Hans Holmen, Arne Martinus Pedersen
  • Patent number: 6248341
    Abstract: The present invention relates to a method of inhibiting angiogenesis in mammalian tissue which comprises supplying to the tissue a composition comprising an effective amount of epigallocatechin-gallate, epicatechin gallate or a combination thereof. The method is particularly useful in the treatment of angiogenesis-related skin conditions in which the catechin is applied topically, such as the treatment of various skin cancers, psoriasis, spider veins or undereye circles.
    Type: Grant
    Filed: January 14, 2000
    Date of Patent: June 19, 2001
    Assignee: Color Access, Inc.
    Inventors: Jon Anderson, Mary Steidl Matsui
  • Patent number: 6248352
    Abstract: The invention encompasses compounds corresponding to the formula in which R1 denotes a C1-C31, preferably C9-C25, hydrocarbon-comprising radical, in particular a saturated or unsaturated, linear or branched, C1-C31, preferably C9-C25, alkyl radical which can be substituted by one or more optionally esterified hydroxyls; and OR2 denotes a cholesteryl radical; the said compounds being in the form of a pure enantiomer or in the form of a mixture of isomers. The invention also relates to their process of preparation and to their use, in particular for the treatment and care of the skin, hair, nails and eyelashes, in cosmetics or in dermatology.
    Type: Grant
    Filed: March 10, 1999
    Date of Patent: June 19, 2001
    Assignee: L'Oreal S.A.
    Inventors: Didier Semeria, Michel Philippe
  • Patent number: 6245340
    Abstract: Method for enhancing the immune system of a patient by orally administering to the patient safflower seeds or an extract of safflower seeds in combination with a pharmaceutically acceptable vehicle.
    Type: Grant
    Filed: July 30, 1999
    Date of Patent: June 12, 2001
    Inventor: Parvin Youssefyeh
  • Patent number: 6242000
    Abstract: The use of S(−)sodium 2-(4-isobutylphenyl)propionate (the sodium salt of S(+)-ibuprofen) in pharmaceutical compositions for the treatment of inflammation, pain and pyrexia is described. Preferred compositions comprise S(−)sodium 2-(4-isobutylphenyl)propionate dihydrate. Processes to prepare S(−)sodium 2-(4-isobutyl-phenyl)propionate and its use in a process to prepare S(+) 2-(4-isobutylphenyl)propionic acid of high enantiomeric purity are also described.
    Type: Grant
    Filed: October 2, 1997
    Date of Patent: June 5, 2001
    Assignee: The Boots Company PLC
    Inventors: Bernard John Armitage, John Francis Lampard, Alan Smith
  • Patent number: 6242011
    Abstract: A composition of matter and the method of making that provides a low pH acidic composition that is useful for destroying microorganisms that are undesirable and useful for destroying or reducing melanoma on human skin. The composition and method include sulfuric acid combined with distilled water and ammonium sulfate under at least 15 psi pressure in a pressurized container, all of which is heated to approximately 800° F. or more for at least 3 hours. The final cooled mixture is stabilized with 10 percent of the original mixture. The resultant composition is useful for preserving food, such as fresh fish, and for skin treatment of melanoma.
    Type: Grant
    Filed: August 5, 1999
    Date of Patent: June 5, 2001
    Inventor: Barry W. Cummins
  • Patent number: 6242012
    Abstract: An herbal composition which can be used to alleviate the symptoms associated with hormonal imbalance in women contains supercritical extracts of ginger, rosemary and evening primrose oil, and either regular or supercritical (preferably regular) extracts of black cohosh, dong quai, schizandra berry, chaste tree berry and rosemary. The herbal composition can be administered orally, topically or parenterally. In addition to promoting hormonal balance, the herbal composition also promotes normal bone growth by inhibiting the 5-lipoxygenase enzyme and sustains warmth and normal fluids for healthy sexual functioning. Furthermore, the herbal composition contains organic anti-aging constituents that inactivate free radicals, thereby providing antioxidant activity.
    Type: Grant
    Filed: February 25, 2000
    Date of Patent: June 5, 2001
    Inventors: Thomas Newmark, Paul Schulick
  • Publication number: 20010002407
    Abstract: A method for inhibiting cyclooxygenase enzymes and inflammation in a mammal using a cherry or cherry anthocyanins, bioflavonoids and phenolics is described. In particular a mixture including the anthocyanins, the bioflavonoids and the phenolics is described for this use.
    Type: Application
    Filed: January 16, 2001
    Publication date: May 31, 2001
    Applicant: Board of Trustees operating Michigan State University
    Inventors: Muraleedharan G. Nair, Haibo Wang, Gale M. Strasburg, Alden M. Booren, James I. Gray
  • Patent number: 6238675
    Abstract: The present invention is directed to a method of preparation and the composition of a water soluble extract of the plant species Uncaria. The present invention is also directed to the pharmaceutical use of the composition for the enhancement of the immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals. The present preparation of the water soluble extract of the plant species Uncaria results in the depletion of many of the ingredients which lead to various toxic side effects associated with other extracts or compositions derived from Uncaria. Also, the present preparation leads to the depletion of many of the active ingredients commonly associated with other extracts and compositions of the plant species Uncaria.
    Type: Grant
    Filed: November 16, 1999
    Date of Patent: May 29, 2001
    Assignee: CampaMed Corp.
    Inventor: Ronald W. Pero
  • Patent number: 6235294
    Abstract: The invention relates to a flavonoid ester. This flavonoid ester results from the reaction product of at least one flavonoid selected from the group consisting of a flavonoid with a ketone group in the 4-position, a salt, ester or ether of such a flavonoid, and a C-heteroside and/or O-heteroside derivative of such a flavonoid, with the proviso that this flavonoid contains at least one free alcohol group, with an organic monoacid having from 3 to 30 carbon atoms. These flavonoid esters constitute useful active principles for the manufacture of cosmetic, dermopharmaceutical, pharmaceutical, dietetic or agri-foodstuff compositions.
    Type: Grant
    Filed: July 10, 1998
    Date of Patent: May 22, 2001
    Assignee: Coletica
    Inventors: Eric Perrier, Anne-Marie Mariotte, Ahcéne Boumendjel, Delphine Bresson-Rival
  • Patent number: 6228892
    Abstract: An antiallergic agent which is characterized in containing at least one compound selected from a group consisting of 4,5-dihydroxy-2-cyclopenten-1-one represented by the following formula [I] and an optically active substance and a salt thereof as an effective component.
    Type: Grant
    Filed: November 15, 1999
    Date of Patent: May 8, 2001
    Assignee: Takara Shuzo Co., Ltd.
    Inventors: Takanari Tominaga, Eiji Nishiyama, Michio Hagiya, Nobuto Koyama, Ikunoshin Kato
  • Patent number: 6217885
    Abstract: The present invention relates to antipruritic cosmetic and/or pharmaceutical compositions for use on human or animal skin, comprising one or more mild local anesthetics, one or more astringents and/or, if appropriate, a substance having an antiinflammatory action.
    Type: Grant
    Filed: February 18, 1998
    Date of Patent: April 17, 2001
    Assignee: Bayer Aktiengesellschaft
    Inventors: Klaus Röder, Sabine Koch
  • Patent number: 6217914
    Abstract: An ascorbic acid-based composition and related method for the treatment of aging or photo-damaged skin is disclosed. The composition includes water and ascorbic acid, at least a portion of which has generally been pretreated by being dissolved under relatively high temperature and concentration conditions. The composition typically includes at least about 5.0% (w/v) ascorbic acid and may advantageously be formulated to have a pH above 3.5. Generally, the composition also includes non-toxic zinc salt, tyrosine compound, and/or pharmaceutically acceptable carrier. In addition, the composition may include an anti-inflammatory compound, such as aminosugar and/or sulfur-containing anti-inflammatory compound. The topical composition may be in the form of a serum, a hydrophilic lotion, an ointment, a cream, or a gel.
    Type: Grant
    Filed: July 19, 1999
    Date of Patent: April 17, 2001
    Assignee: Bioderm, Inc.
    Inventor: Lorraine Faxon Meisner
  • Patent number: 6203796
    Abstract: A therapeutic composition comprising oregano oil, laurel oil, and myrtle oil useful in alleviating pain and discomfort associated with arthritis, migraines, bronchitis, soft tissue injuries, muscle aches and pains and neck and back pains and strains in humans, as well as upper respiratory, joint and shin ailments in animals.
    Type: Grant
    Filed: July 8, 1999
    Date of Patent: March 20, 2001
    Inventor: Andreas D. Papaprodromou
  • Patent number: 6200570
    Abstract: The invention provides a herbal formulation useful as a therapeutic and cosmetic applications for the treatment of general skin disorders, the composition comprising at least two or more plant extracts in the form of oil or powder or mixtures thereof, the plant extracts being selected from the group consisting of Gymnena sylvestrae water extract 3 to 6 wt. %; Tridax procumbens water extract 3 to 6 wt. %; its methanolic extract 4 to 6 wt. %, Allium sativum oil hexane extract 1 to 3 wt. %; dried juice of Aloe vera 2 to 6 wt. %; Gum Olibanum powder in the natural form 4 to 7 wt. %; Gum Olibanum resinoid organic solvent extract 3 to 8 wt. %; and resinoid free Gum Olibanum meal 5 to 10 wt. %., optionally, including any drug having anti-inflammatory and wound healing property or mixture thereof, the drug being selected from the group consisting of Disclofenac sodium 1-3 wt. %, Salicyclic acid 1 to 4 wt. %, Piroxicam 1 to 2 wt. %, Turmeric powder 0.1 to 1 wt.
    Type: Grant
    Filed: November 25, 1998
    Date of Patent: March 13, 2001
    Assignee: Counsel of Scientific and Industrial Research
    Inventors: Prakash Vaman Rao Diwan, Bhamidipalli Subrahmanya Sitaramam, Sistla Ramakrishna, Kondapuram Vijaya Raghavan
  • Patent number: 6201011
    Abstract: A therapeutic agent for allergic dermatitis caused by type IV allergic reaction, which contains diethyl L-lysylcromoglycate of the formula: or a nontoxic salt thereof as an active ingredient. This therapeutic agent for allergic dermatitis is effective for the treatment of allergic dermatitis caused by type IV allergic reaction, such as contact dermatitis mainly induced by type IV allergic reaction and atopic dermatitis induced by type I and type IV allergic reactions.
    Type: Grant
    Filed: February 26, 1999
    Date of Patent: March 13, 2001
    Assignee: Kyoto Pharmaceutical Industries, Ltd.
    Inventors: Hiroaki Shirahase, Akihisa Yoshimi, Shohei Nakamura, Mamoru Kanda
  • Patent number: 6194469
    Abstract: A method for inhibiting cyclooxygenase enzymes and inflammation in a mammal using a cherry or cherry anthocyanins, bioflavonoids and phenolics is described. In particular a mixture including the anthocyanins, the bioflavonoids and the phenolics is described for this use.
    Type: Grant
    Filed: June 21, 1999
    Date of Patent: February 27, 2001
    Assignee: Board of Trustees operating Michigan State Univeristy
    Inventors: Muraleedharan G. Nair, Haibo Wang, Gale M. Strasburg, Alden M. Booren, James I. Gray
  • Patent number: 6190691
    Abstract: The present invention provides a number of screening methods for evaluating compounds capable of suppressing cytokine production either in vitro or in vivo. The methods generally involve stimulating the production of a cytokine in a cell, exposing a portion of the cells to a putative cytokine modulating agent and determining subsequent levels of cytokine production in the cells. Additionally, the present invention provides certain compounds identified by this method.
    Type: Grant
    Filed: June 15, 1998
    Date of Patent: February 20, 2001
    Assignee: Adolor Corporation
    Inventor: Vivien H. W. Mak
  • Patent number: 6159711
    Abstract: Modifications to RANTES can result in the modified polypeptide acting as a RANTES or MIP-1.alpha. antagonist. Such antagonists can be used in therapy to reduce inflammation. They are also useful in studying the properties of RANTES or of MIP-1.alpha..
    Type: Grant
    Filed: May 23, 1997
    Date of Patent: December 12, 2000
    Assignee: Glaxo Group Limited
    Inventors: Amanda E. I. Proudfoot, Timothy N. C. Wells
  • Patent number: 6156729
    Abstract: A method for inhibiting and/or reducing inflammation and/or pain in an individual is provided. The method comprises administration of leukemia inhibitory factor (LIF) to a cell or an individual in an amount effective to inhibit and/or reduce inflammation and/or pain.
    Type: Grant
    Filed: October 15, 1998
    Date of Patent: December 5, 2000
    Assignee: California Institute of Technology
    Inventors: Paul H. Patterson, Clifford J. Woolf